Jivita Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-12-2024
- Paid Up Capital ₹ 0.10 M
as on 16-12-2024
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.20 Cr
as on 16-12-2024
- Satisfied Charges ₹ 6.57 Cr
as on 16-12-2024
- Revenue 3.03%
(FY 2023)
- Profit -20.84%
(FY 2023)
- Ebitda -29.52%
(FY 2023)
- Net Worth 11.75%
(FY 2023)
- Total Assets 22.53%
(FY 2023)
About Jivita Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.20 Cr. The company has closed loans amounting to ₹6.57 Cr, as per Ministry of Corporate Affairs (MCA) records.
Dipesh Shah and Dipali Shah serve as directors at the Company.
- CIN/LLPIN
U51909GJ2017PTC099198
- Company No.
099198
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Sep 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Jivita Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dipesh Shah  | Director | 22-Sep-2017 | Current |
| Dipali Shah | Director | 22-Sep-2017 | Current |
Financial Performance of Jivita Healthcare.
Jivita Healthcare Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.03% increase. The company also saw a substantial fall in profitability, with a 20.84% decrease in profit. The company's net worth Soared by an impressive increase of 11.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jivita Healthcare?
Unlock access to Jivita Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 01 Dec 2021 | ₹2.20 Cr | Open |
Others Creation Date: 29 Nov 2022 | ₹1.57 Cr | Satisfied |
Axis Bank Limited Creation Date: 07 Aug 2020 | ₹5.00 Cr | Satisfied |
How Many Employees Work at Jivita Healthcare?
Unlock and access historical data on people associated with Jivita Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jivita Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jivita Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
